CA1339896C - Dideoxydidehydrocarbocyclic nucleosides - Google Patents

Dideoxydidehydrocarbocyclic nucleosides

Info

Publication number
CA1339896C
CA1339896C CA000588614A CA588614A CA1339896C CA 1339896 C CA1339896 C CA 1339896C CA 000588614 A CA000588614 A CA 000588614A CA 588614 A CA588614 A CA 588614A CA 1339896 C CA1339896 C CA 1339896C
Authority
CA
Canada
Prior art keywords
compound
formula
alpha
compound according
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000588614A
Other languages
English (en)
French (fr)
Inventor
Robert Vince
Mei Hua
Peter Leslie Myers
Richard Storer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
University of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/146,252 external-priority patent/US4916224A/en
Priority claimed from GB888821011A external-priority patent/GB8821011D0/en
Priority claimed from US07/278,652 external-priority patent/US4931559A/en
Application filed by University of Minnesota filed Critical University of Minnesota
Application granted granted Critical
Publication of CA1339896C publication Critical patent/CA1339896C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
CA000588614A 1988-01-20 1989-01-19 Dideoxydidehydrocarbocyclic nucleosides Expired - Lifetime CA1339896C (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US07/146,252 US4916224A (en) 1988-01-20 1988-01-20 Dideoxycarbocyclic nucleosides
GB8821011.7 1988-09-07
GB888821011A GB8821011D0 (en) 1988-09-07 1988-09-07 Chemical compounds
US146,252 1988-12-05
US278,652 1988-12-05
US07/278,652 US4931559A (en) 1988-01-20 1988-12-05 Optically-active isomers of dideoxycarbocyclic nucleosides

Publications (1)

Publication Number Publication Date
CA1339896C true CA1339896C (en) 1998-06-02

Family

ID=27264063

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000588614A Expired - Lifetime CA1339896C (en) 1988-01-20 1989-01-19 Dideoxydidehydrocarbocyclic nucleosides

Country Status (29)

Country Link
JP (1) JP2793825B2 (fi)
KR (1) KR0127137B1 (fi)
AT (1) AT397801B (fi)
AU (2) AU626278B2 (fi)
BE (1) BE1003815A4 (fi)
CA (1) CA1339896C (fi)
CH (1) CH679152A5 (fi)
DE (1) DE3901502C2 (fi)
DK (1) DK175131B1 (fi)
ES (1) ES2010091A6 (fi)
FI (1) FI93546C (fi)
FR (1) FR2626002B1 (fi)
GB (1) GB2217320B (fi)
GR (1) GR890100033A (fi)
HU (1) HU203755B (fi)
IE (1) IE62275B1 (fi)
IL (1) IL88999A (fi)
IT (1) IT1229531B (fi)
LU (1) LU87437A1 (fi)
MY (1) MY103801A (fi)
NL (1) NL8900122A (fi)
NO (1) NO169123C (fi)
NZ (1) NZ227663A (fi)
OA (1) OA09031A (fi)
PL (1) PL163814B1 (fi)
PT (1) PT89482B (fi)
RU (1) RU2114846C1 (fi)
SE (1) SE505213C2 (fi)
YU (1) YU47791B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
ES2136061T3 (es) * 1989-06-27 1999-11-16 Wellcome Found Nucleosidos terapeuticos.
GB8916480D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916477D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
US5241069A (en) * 1990-04-06 1993-08-31 Glaxo Inc. Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
CN1137274A (zh) * 1993-11-12 1996-12-04 默里尔药物公司 用作免疫抑制剂的6-氧代-核苷
GB9721780D0 (en) 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
KR100606625B1 (ko) 1998-10-30 2006-07-28 론자 아게 4-[(2',5'-디아미노-6'-할로피리미딘-4'-일)아미노]-시클로펜트-2-에닐메탄올의 제조 방법
HU227559B1 (en) * 1998-10-30 2011-08-29 Lonza Ag Method for producing 4-[(2',5'-diamino-6'-halopyrimidine-4'-yl)amino]-cyclopent-2-enylmethanols
TWI229674B (en) * 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
TW202019942A (zh) 2018-07-27 2020-06-01 日商富士軟片股份有限公司 環戊烯嘌呤衍生物或其鹽
JP2023519882A (ja) 2020-03-27 2023-05-15 ソム、イノベーション、バイオテック、ソシエダッド、アノニマ シヌクレイノパチーの治療に有用な化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
JPS62177234A (ja) * 1986-01-30 1987-08-04 Mitsubishi Heavy Ind Ltd 遠心紡糸によるカ−ボン繊維の製造装置
IN164556B (fi) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.

Also Published As

Publication number Publication date
YU47791B (sr) 1996-01-09
AU2867189A (en) 1989-07-20
IL88999A0 (en) 1989-08-15
OA09031A (en) 1991-03-31
IE62275B1 (en) 1995-01-25
PT89482B (pt) 1994-02-28
GB8901187D0 (en) 1989-03-15
NO890253D0 (no) 1989-01-19
NO169123C (no) 1992-05-13
JP2793825B2 (ja) 1998-09-03
ATA10689A (de) 1993-11-15
LU87437A1 (fr) 1989-08-30
AT397801B (de) 1994-07-25
PL163814B1 (en) 1994-05-31
FI93546B (fi) 1995-01-13
DK23489D0 (da) 1989-01-19
NL8900122A (nl) 1989-08-16
PL277261A1 (en) 1989-09-18
NO890253L (no) 1989-07-21
KR890011902A (ko) 1989-08-23
IT1229531B (it) 1991-09-04
IL88999A (en) 1994-12-29
FI93546C (fi) 1995-04-25
CH679152A5 (fi) 1991-12-31
SE8900192L (sv) 1989-07-21
JPH02196788A (ja) 1990-08-03
MY103801A (en) 1993-09-30
SE505213C2 (sv) 1997-07-14
BE1003815A4 (fr) 1992-06-23
DE3901502C2 (de) 2002-06-13
AU1018092A (en) 1992-03-12
GB2217320B (en) 1992-04-08
IT8947546A0 (it) 1989-01-19
KR0127137B1 (ko) 1997-12-29
ES2010091A6 (es) 1989-10-16
HUT48887A (en) 1989-07-28
HU203755B (en) 1991-09-30
GR890100033A (el) 1994-03-31
AU637015B2 (en) 1993-05-13
AU626278B2 (en) 1992-07-30
GB2217320A (en) 1989-10-25
YU12389A (en) 1991-10-31
IE890153L (en) 1989-07-20
NZ227663A (en) 1990-09-26
FI890286A0 (fi) 1989-01-19
FR2626002B1 (fr) 1994-01-28
PT89482A (pt) 1989-10-04
DK23489A (da) 1989-07-21
FI890286A (fi) 1989-07-21
FR2626002A1 (fr) 1989-07-21
DE3901502A1 (de) 1989-07-27
NO169123B (no) 1992-02-03
RU2114846C1 (ru) 1998-07-10
DK175131B1 (da) 2004-06-14
SE8900192D0 (sv) 1989-01-19

Similar Documents

Publication Publication Date Title
CA1339896C (en) Dideoxydidehydrocarbocyclic nucleosides
AP91A (en) Dideoxydidehydrocarbocyclic nucleosides.
RU2037496C1 (ru) Пуринил- или пиримидинилпроизводные метиленциклопентила
US5538975A (en) 1,3-oxathiolane nucleoside compounds and compositions
US5962684A (en) Method of preparation of dideoxycarbocyclic nucleosides
CZ658390A3 (en) Enantiomeric purine derivatives, process of their preparation, pharmaceutical compositions containing thereof and their use
EP0291229B1 (en) 9(2-(hydroxymethyl) cycloalkylmethyl)guanines
EP0346132B1 (en) Pharmaceutical products
US4950758A (en) Optically-active isomers of dideoxycarbocyclic nucleosides
US4931559A (en) Optically-active isomers of dideoxycarbocyclic nucleosides
GB2243609A (en) Carbocyclic nucleosides
CN1031055C (zh) 二脱氧二脱氢碳环核苷的制备方法
SI8910123A (sl) Dideoksidihidrokarbocikličninukleozidi
Boumchita et al. New cyclobutyl analogs of nucleosides. Part 2. Synthesis and antiviral evaluation of 2-amino-7-[3, 3-bis (hydroxymethyl) cyclobut-1-yl]-3H, 7H-pyrrolo-[2, 3-d] pyrimidin-4-one and of cyclobutyl analogs of the pyrimidine nucleosides
JPH05178746A (ja) 抗ウイルス剤

Legal Events

Date Code Title Description
MKEX Expiry

Effective date: 20150602